CompoAtlas

PASCOFEMIN® Tablets

Natural health product licensed in Canada

Licence holder
Pascoe Canada
NPN or DIN-HM
80011380
Status
Active licence
Licence date
3 July 2009
Revision date
4 September 2024
Form
Comprimé
Route of administration
Orale
Application type
Homéopathique

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Aletris farinosa

Source : Parties souterraines

Potency : 10 mg 3X

3 XNot calculated
Cimicifuga racemosa

Source : Racine

Potency : 30 mg 6X

6 XNot calculated
Cimicifuga racemosa

Source : Rhizome(s)

Potency : 30 mg 6X

6 XNot calculated
Vitex agnus-castus

Source : Fruit(s)

Potency : 30 mg 2X

2 XNot calculated
Pulsatilla pratensis

Source : Plante entière fleurissante

Potency : 10 mg 4X

4 XNot calculated
Caulophyllum thalictroides

Source : Parties souterraines

Potency : 10 mg 2X

2 XNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Lactose monohydrate, Starch, Corn

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Compriméminimum: 1 Tous les jours ; maximum: 3 Tous les jours
Enfantsminimum: 12 years1 Compriméminimum: 1 Tous les jours ; maximum: 3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Homeopathic remedy used to relieve symptoms associated with menopause, PMS, and other hormonal disturbances such as hot flashes, sleep disorders, bloating, mood swings, irritability, breast tenderness, abdominal pain, headaches.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80011380

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line